Search Results
Feb 02, 2026, 20:00 ET ITGR Deadline: ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit
the growing electrophysiology ("EP") manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, Integer was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: THE ROSEN LAW FIRM, P. A.
Feb 02, 2026, 06:00 ET LUMA Vision VERAFEYE System to be Featured at AF Symposium In Recorded Case Presentation
The case will be presented by Ante Anić, MD, EP Lab Director at University Hospital Split, and was performed as part of a clinical study evaluating VERAFEYE's performance in real-world ablation workflows."The
More news about: LUMA Vision
Jan 30, 2026, 00:33 ET FRONTERA ANNOUNCES DEFINITIVE AGREEMENT WITH GEOPARK TO DIVEST ITS COLOMBIAN E&P ASSETS PORTFOLIO FOR A FIRM VALUE OF $622 MILLION
content:https://www.prnewswire.com/news-releases/frontera-announces-definitive-agreement-with-geopark-to-divest-its-colombian-ep-assets-portfolio-for-a-firm-value-of-622-million-302674828.htmlSOURCE
More news about: Frontera Energy Corporation
Jan 29, 2026, 09:00 ET CathVision Demonstrates Clinical Progress in Pulsed Field Ablation With PFAnalyzer - Advancing Lesion Assessment and Restoring Electrogram-Driven Electrophysiology
progress in Pulsed Field Ablation (PFA) with its PFAnalyzer™ software module, reinforcing the company's differentiated position in electrophysiology (EP) recording and analysis. The work demonstrates how high-fidelity unipolar electrograms can be re-established as a practical and clinically relevant tool
More news about: CathVision
Jan 28, 2026, 21:00 ET Biến động giá vàng chiếm vị trí trung tâm trong báo cáo triển vọng thị trường của Mitrade năm 2026, phù hợp với tâm lý giao dịch CFD tại châu Á
HÀ NỘI, Việt Nam, ngày 29 tháng 1 năm 2026 /PRNewswire/ -- Khi các thị trường tài chính bước vào năm 2026 dưới sức ép của bất ổn kinh tế vĩ mô, sự thay đổi trong chính sách tiền tệ và rủi ro địa chính trị, vàng giao ngay một lần nữa nổi lên là một trọng tâm quan trọng đối với các nhà giao dịch
More news about: Mitrade Group
Jan 28, 2026, 14:57 ET Kuehn Law Encourages Investors of Integer Holdings Corporation to Contact Law Firm
competitive position within the growing EP manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: Kuehn Law, PLLC
Jan 28, 2026, 12:00 ET Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
competitive position within the growing EP manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: Glancy Prongay & Murray LLP
Jan 28, 2026, 07:00 ET Corify Care Introduces First Whole-Heart Mapping Technology, Delivering a Global View of Cardiac Arrhythmias in a Single Beat
decisions, more targeted ablations, and the potential to reduce procedure time and complexity, providing clinical clarity" Designed for the EP Lab of the Future Corify Care's system uncovers arrhythmia pathways that are often missed with conventional tools, including circuits located
More news about: Corify Care
Jan 27, 2026, 23:55 ET ITGR Deadline: ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit
the growing electrophysiology ("EP") manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, Integer was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: THE ROSEN LAW FIRM, P. A.
Jan 26, 2026, 17:31 ET RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
increasingly moving toward precision-driven approaches. Additionally, the launch of emerging therapies such as Sacituzumab tirumotecan (Merck & Co.), EP0031 (Ellipses Pharma), and others will further propel the market growth.LAS VEGAS, Jan.
More news about: DelveInsight Business Research, LLP
Jan 26, 2026, 01:43 ET Nét cọ tỷ đô: Nền tảng nghệ thuật do luật sư sáng lập đạt hơn 1 tỷ USD giá trị tác phẩm được cam kết đưa lên đấu giá trong tháng đầu tiên - sẵn sàng cho tăng trưởng bứt phá.
tới những tài năng mới nổi. "Sứ mệnh của chúng tôi là đưa nghệ thuật trở nên dễ tiếp cận với tất cả mọi người theo một cách an toàn và không mang tính ép buộc", Cassin tiếp tục. "Với việc mỗi tác phẩm đều được kiểm chứng nghiêm ngặt và xác thực độc lập – kể cả bởi một chuyên gia do người mua lựa chọn
More news about: Lloyds Auctions
Jan 23, 2026, 15:30 ET Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
competitive position within the growing EP manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: Law Offices of Howard G. Smith
Jan 22, 2026, 20:08 ET ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit
the growing electrophysiology ("EP") manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, Integer was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: THE ROSEN LAW FIRM, P. A.
Jan 21, 2026, 13:22 ET Enverus releases Top 50 Public E&P Operators of 2025
download multimedia:https://www.prnewswire.com/news-releases/enverus-releases-top-50-public-ep-operators-of-2025-302667090.htmlSOURCE
More news about: Enverus
Jan 21, 2026, 07:04 ET Thesis Gold Intersects 38.00 Metres of 3.62 g/t Au at Steve Zone, Ranch Project
BC, Jan. 21, 2026 /PRNewswire/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) (OTCQX: THSGF) is pleased to announce assay results from the 2025 drill program at the Steve Zone, part of the 100% owned Lawyers-Ranch gold-silver
More news about: Thesis Gold Inc.
Jan 20, 2026, 15:15 ET Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
competitive position within the growing EP manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jan 20, 2026, 09:03 ET Founders Row Backs Early-Stage AI Sports Analytics Platform Elite Picks
machine-learning infrastructure, the platform analyzes more than two million data points to generate predictive insights and performance signals, including its core EP Score, a 0–100 rating system that translates complex analytics into clear, consumer-friendly decision-making.Zakkour brings a deep technical background
More news about: Founders Row
Jan 20, 2026, 09:00 ET Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
https://www.cardiovascular.abbott/us/en/ep-clinical-evidence/volt-clinical-evidence.htmlEnSite™ X EP System
More news about: Abbott
Jan 20, 2026, 06:00 ET AorticLab S.r.l. Announces Clear Victory Before the European Unified Patent Court in Litigation Brought by Emboline, Inc.
protection device has received full clearance following the Unified Patent Court's clear dismissal of Emboline's infringement claims regarding European Patent EP 2129425, ensuring continued patient access to its innovative technology COLLERETTO GIACOSA,
More news about: AorticLab
Jan 17, 2026, 12:46 ET ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit
the growing electrophysiology ("EP") manufacturing market; (2) despite Integer's claims of strong visibility into customer demand, Integer was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth
More news about: THE ROSEN LAW FIRM, P. A.
Jan 15, 2026, 12:09 ET XREAL Files U.S. Patent Infringement Lawsuit against Viture to Defend Foundational Augmented Reality Technology
against Eden Future HK Limited, a Viture affiliate, after finding a strong likelihood that the accused Viture's products infringe XREAL's European patent EP3754409B1 related to augmented reality devices and optical systems. The court found that the accused Viture Pro product fall within the scope of XREAL's
More news about: XREAL
Jan 14, 2026, 21:24 ET Thesis Gold Files Pre-Feasibility Technical Report for the Lawyers-Ranch Gold-Silver Project
BC, Jan. 14, 2026 /PRNewswire/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) (OTCQX: THSGF) is pleased to announce the filing on SEDAR+ of the Pre-feasibility Study (the "2025 PFS") for the wholly owned Lawyers-Ranch
More news about: Thesis Gold Inc.
Jan 14, 2026, 10:52 ET Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
need."The company's selective CBP degrader program with potential in ER-positive breast cancer is on track to be IND-ready in 2026, while the selective EP300 degrader program shows preclinical superior anti-tumor efficacy. Foghorn maintains cash, cash equivalents and marketable securities of $208.9
More news about: Equity Insider
Jan 14, 2026, 03:40 ET ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law Firm
statements to the market. Integer exaggerated its competitive positioning in the electrophysiology ("EP") market. The Company suffered a weakening in sales of several different EP devices. The Company falsely claimed EP devices would be a long-term growth driver within the cardio and vascular ("C&V") segment.
More news about: The Schall Law Firm
Jan 14, 2026, 02:43 ET Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ITGR
2026CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Integer claimed its electrophysiology ("EP") devices would drive long-term growth in the cardio and vascular ("C&V") segment but was actually suffering from eroding sales due to the competitive
More news about: DJS Law Group LLP